Gene · 5094
Papers1,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicles: Classification, Biological Functions, Diseases, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 42769510 | PubTator, text mining | PubMed |
| PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines. | Mol Ther Nucleic Acids | 2026 | 42732236 | PubTator, text mining | PubMed |
| RETRACTION: PCBP2 Promotes the Development of Glioma by Regulating FHL3/TGF-β/Smad Signaling Pathway. | J Cell Physiol | 2026 | 42627232 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circLPAR3 drives docetaxel resistance in prostate cancer by suppressing ferroptosis through the PCBP2/CHAC1 axis. | Genes Dis | 2026 | 42621305 | PubTator, text mining | PubMed |
| TDP-43 drives ferroptosis evasion by modulating PCBP1/PCBP2 axis to promote lung adenocarcinoma growth. | Redox Biol | 2026 | 42585793 | PubTator, text mining | PubMed |
| The lncRNA Gm16685 / MITA1 modulates inflammatory astrocyte reactivity through PCBP2 associated regulation of IKKβ signaling. | bioRxiv | 2026 | 42465384 | PubTator, text mining | PubMed |
| EGFR mimotope alleviates renal fibrosis by promoting EGFR/RPL6/PCBP2 ternary complex formation. | NPJ Vaccines | 2026 | 42399607 | PubTator, text mining | PubMed |
| A novel role of circCPSF6 regulating antiviral innate immunity via miR-665 and PCBP2-IPS-1 axis in IAV infection. | Mol Ther Nucleic Acids | 2026 | 42367247 | PubTator, text mining | PubMed |
| Radiation-Induced Tumor-Intrinsic LTβR N-Glycosylation Suppresses Pyroptosis Through TRIM28-Mediated PCBP2 SUMOylation to Promote Gastric Cancer Radioresistance. | Adv Sci (Weinh) | 2026 | 42325190 | PubTator, text mining | PubMed |
| A P-body-related risk score predicts prognosis and immune microenvironment in lung adenocarcinoma. | Transl Cancer Res | 2026 | 42305460 | PubTator, text mining | PubMed |
| Transcriptional Control by FOXO4 Regulates Trophoblast Differentiation and Safeguards Placental Development Through MITD1- and PCBP2-Mediated Redox Homeostasis. | FASEB J | 2026 | 42201761 | PubTator, text mining | PubMed |
| Analysis of B cell dynamic changes and pivotal drivers based on single-cell transcriptome of peripheral blood in sepsis. | Blood Cells Mol Dis | 2026 | 42184475 | PubTator, text mining | PubMed |
| Integrative RNA-seq and iRIP-seq analysis links SNRPA overexpression to transcriptomic and splicing alterations in hepatocellular carcinoma cells. | Front Oncol | 2026 | 42147247 | PubTator, text mining | PubMed |
| eEF2K-Mediated Stabilization of PCBP2 Promotes Oncogenic mRNA Programs in Triple-Negative Breast Cancer. | Int J Biol Sci | 2026 | 42003905 | PubTator, text mining | PubMed |
| Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy. | Exp Hematol Oncol | 2026 | 41928285 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K in cancer biology and its therapeutic applications (Review). | Mol Med Rep | 2026 | 41891975 | PubTator, text mining | PubMed |
| Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes. | Proc Natl Acad Sci U S A | 2026 | 41880578 | PubTator, text mining | PubMed |
| Impact of poly(rC)-binding protein 2 (PCBP2) on the malignant phenotype of cholangiocarcinoma. | Biochem Pharmacol | 2026 | 41876016 | PubTator, text mining | PubMed |
| SNHG7 interacts with PCBP2 to promote CDKN2A expression and modulate cuproptosis in colorectal cancer. | Transl Oncol | 2026 | 41875809 | PubTator, text mining | PubMed |
| PCBP2 mediates MTUS1 degradation through 3'-UTR binding to restrict pyroptosis and augment malignant progression in esophageal squamous cell carcinoma. | Esophagus | 2026 | 41851529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5094/papers